Error: Could not add to watchlist. X

Franklin Strategic Series - Franklin Biotechnology Discovery Fund

+ Watchlist
FBDIX:US
NASDAQ GM
186.87
USD
4.77
2.62%
As of 09:29:30 ET on 08/27/2015.
Fund Type
Open-End Fund
52Wk Range
141.29 - 216.54
1 Yr Return
22.00%
YTD Return
10.86%
Previous Close
182.10
52Wk Range
141.29 - 216.54
1 Yr Return
22.00%
YTD Return
10.86%
Fund Type
Open-End Fund
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
U.S.
NAV (on 08/27/2015)
186.87
Total Assets (b USD) (on 07/31/2015)
2.102
Inception Date
09/15/1997
Last Dividend (on 12/15/2014)
3.7275
Dividend Indicated Gross Yield
-
Fund Managers
EVAN MCCULLOCH / JEREL ANTHONY BANKS
Front Load Fee
5.75%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
0.35%
Current Mgmt Fee
0.59%
Expense Ratio
1.00%
Top Fund Holdings
Name Position Value % of Fund
Gilead Sciences Inc 1.56 m 182.68 m 8.88
Celgene Corp 1.46 m 169.29 m 8.23
Biogen Inc 351.46 k 141.97 m 6.90
Amgen Inc 562.60 k 86.37 m 4.20
Incyte Corp 676.70 k 70.52 m 3.43
Regeneron Pharmaceuticals Inc 129.21 k 65.91 m 3.20
BioMarin Pharmaceutical Inc 471.26 k 64.46 m 3.13
Illumina Inc 266.70 k 58.24 m 2.83
Medivation Inc 464.55 k 53.05 m 2.58
Heron Therapeutics Inc 1.70 m 52.91 m 2.57
Profile
Franklin Biotechnology Discovery Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund invests at least 80% of its net assets in securities of biotechnology companies and discovery research firms. The Fund invests a substantial portion of its assets in equity securities of smaller capitalization companies.
ADDRESS
One Franklin Parkway
Building 970, 1st Floor
San Mateo, CA 94403
PHONE
(800) 632-2350